度普利尤单抗对斑贴试验结果及过敏性接触性皮炎的影响:前瞻性多中心研究
这项前瞻性多中心研究纳入76例接受度普利尤单抗(DUPI)治疗并完成斑贴试验(PT)的患者,36例(47%)至少1项PT阳性,23例(30%)至少1项阳性且临床相关,其中5例避免过敏原后湿疹改善。36例患者治疗前后共1230对PT过敏原中1022对结果一致。作者认为PT在DUPI治疗患者中具有良好可重复性,建议部分应答或症状加重的AD患者行PT排查接触致敏。
要点
- 76例DUPI治疗患者中36例(47%)至少1项PT阳性,23例(30%)至少1项阳性且临床相关。
- 36例患者治疗前后1230对PT过敏原中1022对结果相同,提示PT可重复性良好。
- 5例临床相关PT阳性患者避免过敏原后湿疹改善。
核心结论
- 结果证实PT对接受DUPI的患者有用,且PT可重复性良好。
- 建议所有出现部分应答或症状加重的DUPI治疗AD患者行PT以排查接触致敏。
研究设计与样本
- 前瞻性多中心研究,纳入76例接受DUPI治疗并完成PT的患者,信息于3次访视中收集。
主要发现
- 总体36例(47%)至少1项PT阳性,共142项PT结果阳性。
- 23例(30%)至少1项PT阳性且临床相关,其中5例避免过敏原后临床湿疹改善。
- 36例患者治疗前后共1230对PT过敏原中,1022对结果相同,34对阳性,44对丢失,130对无法判读。
临床怎么用
- 对DUPI治疗中出现部分应答或症状加重的AD患者,可行PT排查接触致敏。
局限性
- 原文述纳入患者数量仍有限,研究结果需在更大样本中确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Limited and conflicting data have been reported on the impact of dupilumab (DUPI) on patch test (PT) results and its efficacy against allergic contact dermatitis (ACD). OBJECTIVE: This study was undertaken to analyze PT reactivities and relevance during treatment with DUPI to determine whether they could detect ACD in patients with uncontrolled or worsened atopic dermatitis (AD) who were receiving this agent. METHODS: This prospective, multicenter study examined 76 DUPI-treated patients who had undergone PTs. The relevant information was collected during 3 visits. RESULTS: Overall, 36 patients (47%) had ≥1 positive PT reaction, and 142 PT results were positive. Twenty-three patients (30%) had ≥1 positive and clinically relevant PT result. Five of them had clinical eczema improvement after allergen avoidance. We compared the PT results of 36 patients before and during DUPI therapy, representing 1230 paired PT allergens, of which 1022 were the same, 34 were positive, 44 were lost, and 130 were uninterpretable. LIMITATIONS: Because the number of patients included remains limited, our findings should be confirmed with a larger sample. CONCLUSION: Our results confirmed the usefulness of PTs for patients receiving DUPI, with good PT reproducibility. We suggest that all DUPI-treated patients with AD developing partial responses or experiencing symptom worsening should undergo PTs to look for contact sensitization.
引用
- Bocquel S, Soria A, Raison-Peyron N, et al. Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study. J Am Acad Dermatol. 2023. PMID: 37871801. doi:10.1016/j.jaad.2023.10.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。